RxDoctor Payments Data

Eli Diamond, MD

Neurology · New York, NYNPI 1477721140

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in NY, where the typical reported total is $913.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$2,078,999in research payments, 2019–2025

Across 61 payments — averaging $34,082 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$1.3M
  • Pfizer$824K

How this compares

$0 in reported general payments places this provider in the 10th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York

Medicare billing

Part B allowed, 2024
$37,966
Medicare patients
147
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TafinlarDabrafenib Mesylate47$295,221
CotellicCobimetinib Fumarate80$275,198
MekinistTrametinib Dimethyl Sulfoxide26$144,159
ZelborafVemurafenib11$32,426
TrexallMethotrexate Sodium12$3,964
AmantadineAmantadine Hcl15$595
Valproic AcidValproic Acid (As Sodium Salt)12$556
Methylphenidate Hcl11$463

Paid to pharmacies, not to this prescriber.

Other neurology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →